{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:08:04Z","timestamp":1791259684515,"version":"4.1.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR050026"],"award-info":[{"award-number":["R01 AR050026"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR070254"],"award-info":[{"award-number":["P30 AR070254"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02696","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T05:14:05Z","timestamp":1542690845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Erika","family":"Darrah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon T.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian F.","family":"Konig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Clifton O.","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonye K.","family":"Danoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrrheum.2012.134","article-title":"Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis","volume":"8","author":"Arend","year":"2012","journal-title":"Nat Rev Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"815038","DOI":"10.4061\/2011\/815038","article-title":"A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis","volume":"2011","author":"Taylor","year":"2011","journal-title":"Autoimmune Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/BOR.0b013e328336ba63","article-title":"The rheumatoid arthritis HLA-DRB1 shared epitope","volume":"22","author":"Holoshitz","year":"2010","journal-title":"Curr Opin Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2174\/1389450116666150202160954","article-title":"Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation","volume":"16","author":"Witalison","year":"2015","journal-title":"Curr Drug Targets"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jmb.2007.01.054","article-title":"Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro","volume":"367","author":"Raijmakers","year":"2007","journal-title":"J Mol Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e81259","DOI":"10.1371\/journal.pone.0081259","article-title":"PADI2 is significantly associated with rheumatoid arthritis","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS ONE"},{"key":"B7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ng1206","article-title":"Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis","volume":"34","author":"Suzuki","year":"2003","journal-title":"Nat Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1002\/art.22983","article-title":"Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation","volume":"56","author":"Foulquier","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.23618","article-title":"Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis","volume":"58","author":"Kinloch","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s13075-014-0498-9","article-title":"Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen","volume":"16","author":"Damgaard","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/ard.2011.151712","article-title":"Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis","volume":"71","author":"Darrah","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/art.40035","article-title":"High-titer rheumatoid arthritis antibodies preferentially bind fibrinogen citrullinated by peptidylarginine deiminase 4","volume":"69","author":"Blachere","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/ard.2008.094490","article-title":"Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents","volume":"68","author":"Halvorsen","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.2007.080267","article-title":"Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity","volume":"67","author":"Halvorsen","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/art.23596","article-title":"Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis","volume":"58","author":"Harris","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B16","doi-asserted-by":"publisher","first-page":"186ra65","DOI":"10.1126\/scitranslmed.3005370","article-title":"Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity","volume":"5","author":"Darrah","year":"2013","journal-title":"Sci Transl Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e98794","DOI":"10.1371\/journal.pone.0098794","article-title":"Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease","volume":"9","author":"Giles","year":"2014","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-016-1126-7","article-title":"Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans","volume":"18","author":"Navarro-Millan","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.autrev.2016.03.016","article-title":"Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage in patients with rheumatoid arthritis","volume":"15","author":"Seaman","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3899\/jrheum.090670","article-title":"Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific","volume":"37","author":"Kobayashi","year":"2010","journal-title":"J Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/ar2131","article-title":"A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis","volume":"9","author":"Gourraud","year":"2007","journal-title":"Arthritis Res Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/art.20316","article-title":"Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/art.21630","article-title":"A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity","volume":"54","author":"Gourraud","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/rheumatology\/kev440","article-title":"Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: association with disease activity and inflammatory markers","volume":"55","author":"Damgaard","year":"2016","journal-title":"Rheumatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02696\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T05:14:06Z","timestamp":1542690846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02696\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2018.02696"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02696","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"article-number":"2696"}}